Title
502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer
Recommended Citation
Bakouny Z, Grover P, Labaki C, Awosika J, Gulati S, Hsu CY, Bilen MA, Eton O, Fecher L, Hwang C, Khan H, McKay RR, Ruiz E, Weissmann L, Thompson MA, Shah D, Warner J, Shyr Y, Choueiri TK, Wise-Draper T. 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer. Ann Oncol. 2022 Sep;33:S772–3. doi: 10.1016/j.annonc.2022.07.630. Epub 2022 Sep 13. PMCID: PMC9472565.
Document Type
Abstract